Metabolomic and Lipidomic Characterization of Meningioma Grades Using LC–HRMS and Machine Learning
Journal of the American Society for Mass Spectrometry · 04.10.2023 · 34 (10) · 2187-2198
DOI: 10.1021/jasms.3c00158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, online erschienen am 14.09.2023. Verfasst von Hoda Safari Yazd und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Florida, Gainesville, Florida 32610, United States. Hauptthemen laut MEDLINE: Meningioma, Meningeal Neoplasms, Brain Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: University of Florida.
Abstract (Originalsprache)
Meningiomas are among the most common brain tumors that arise from the leptomeningeal cover of the brain and spinal cord and account for around 37% of all central nervous system tumors. According to the World Health Organization, meningiomas are classified into three histological subtypes: benign, atypical, and anaplastic. Sometimes, meningiomas with a histological diagnosis of benign tumors show clinical characteristics and behavior of aggressive tumors. In this study, we examined the metabolomic and lipidomic profiles of meningioma tumors, focusing on comparing low-grade and high-grade tumors and identifying potential markers that can discriminate between benign and malignant tumors. High-resolution mass spectrometry coupled to liquid chromatography was used for untargeted metabolomics and lipidomics analyses of 85 tumor biopsy samples with different meningioma grades. We then applied feature selection and machine learning techniques to find the features with the highest information to aid in the diagnosis of meningioma grades. Three biomarkers were identified to differentiate low- and high-grade meningioma brain tumors. The use of mass-spectrometry-based metabolomics and lipidomics combined with machine learning analyses to prospect and characterize biomarkers associated with meningioma grades may pave the way for elucidating potential therapeutic and prognostic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Florida, Gainesville, Florida 32610, United States.
- Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida 32610, United States.
ORCID-Profile: Richard A Yost, Timothy J Garrett
Förderung
- University of Florida
Zitieren
APA
Safari Yazd, H., Bazargani, S. F., Fitzpatrick, G., Yost, R. A., Kresak, J., & Garrett, T. J. (2023). Metabolomic and Lipidomic Characterization of Meningioma Grades Using LC–HRMS and Machine Learning. Journal of the American Society for Mass Spectrometry, 34(10), 2187-2198. https://doi.org/10.1021/jasms.3c00158
Vancouver
Safari Yazd H, Bazargani SF, Fitzpatrick G, Yost RA, Kresak J, Garrett TJ. Metabolomic and Lipidomic Characterization of Meningioma Grades Using LC–HRMS and Machine Learning. Journal of the American Society for Mass Spectrometry. 2023;34(10):2187-2198. doi:10.1021/jasms.3c00158
BibTeX
@article{SafariYazd2023,
author = {Safari Yazd, Hoda and Bazargani, Sina Feizbakhsh and Fitzpatrick, Garrett and Yost, Richard A and Kresak, Jesse and Garrett, Timothy J},
title = {Metabolomic and Lipidomic Characterization of Meningioma Grades Using LC–HRMS and Machine Learning},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2023},
volume = {34},
number = {10},
pages = {2187--2198},
doi = {10.1021/jasms.3c00158}
}
EUVIMED